Regentis Biomaterials RGNT
NYSE RGNT
$1.26 -0.07 (-5.27%)
As of: Nov 11, 2026 · 1:03 PM EST

Regentis Biomaterials (RGNT) Cash & Equivalents (2024 - 2026)

Updated

Regentis Biomaterials (RGNT) recorded Cash & Equivalents of $8.95 million in Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Regentis Biomaterials reported Cash & Equivalents of $7.38 million.

  • Across earlier years, Cash & Equivalents came in at $229,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 5.46 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 4.05 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 5.68 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 2.98 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 1.69 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 3.27 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 609.00 Mn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 3.11 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 2.32 Bn
10 Regentis Biomaterials 6.78 Mn -2.17 Mn - 8.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.95 Mn
Dec 31, 2025 7.38 Mn
Dec 31, 2024 229,000.00
API Access

Regentis Biomaterials Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RGNT&period=max&api_key=YOUR_API_KEY